Trump signs executive order to expand telehealth, boost rural health care With AstraZeneca deal, Wockhardt joins U.K.'s coronavirus vaccine manufacturing push Did insiders trade illegally ahead of Kodak's manufacturing deal? Sen. Warren wants to know Tenet CEO calls June ‘the turning point’ for turbulent second quarter After CEO-switching saga CureVac names full-time chief, CSO Healthcare roundup: CMS to allow temporary premium reductions in individual market Biopharma roundup: NIH picks Lilly for first antibody study; State AGs urge U.S. to allow remdesivir copies Quartet taps SilverCloud Health to broaden access to digital mental health services Honeywell adds COVID vaccine-ready vials to its new line of glass alternatives Investment firm GI Partners snaps up Clinical Ink amid digital trial boom Bayer's Eylea shows pandemic resilience, but major China price cut drags on business Featured Story | By Heather Landi President Donal Trump issued an executive order Monday to support healthcare in rural areas by permanently expanding some telehealth services beyond the COVID-19 pandemic. Here is what the administration plans to do. read more |
| |
|---|
|
| | New vaccines will save lives. Who will save the vaccines? The world’s pharmaceutical cold chains do not at this time have the equipment and scale to safely and compliantly deliver a temperature-sensitive COVID-19 vaccine. Click to learn more about emerging trends in vaccine logistics and distribution.
*Republished with permission, this article first appeared on UPS’s thought leadership blog, Longitudes. |
Top Stories By Fraiser Kansteiner Mumbai, India-based pharma Wockhardt has signed up for fill-finish duties on AstraZeneca's Oxford-partnered COVID-19 shot, using a manufacturing site in Wales. It's setting aside capacity there for other candidates as well, as part of a broader deal to build out U.K. stores of vaccine hopefuls. read more By Eric Sagonowsky Democratic Sen. Elizabeth Warren is asking the SEC to investigate Kodak stock trades made before the Trump administration announced a $765 million funding deal with the company. In a letter to agency Chairman Jay Clayton, she highlighted trades by company executives and others, questioning whether any were based on knowledge of the deal talks. read more By Robert King,Tina Reed Tenet Healthcare announced $88 million in profits from the second quarter as provider relief funds offset major declines in patient volume. read more By Amirah Al Idrus Even as it scrambled to pitch in against the COVID-19 pandemic, CureVac found itself embroiled in a game of executive musical chairs. Now, as it pushes an mRNA vaccine toward the clinic, it’s named a permanent chief, Franz-Werner Haas, and signed a Novartis alum, Igor Splawski, Ph.D. as its new top scientist. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner The NIH is launching a test of monoclonal antibodies for COVID-19, starting with one from Eli Lilly. Four ex-FDA chiefs urged U.S. officials to press for blood plasma trials. A bipartisan group of AGs wants the feds to open Gilead Sciences's remdesivir to generic rivals. And Honeywell has one answer to a vaccine vial shortage. read more By Heather Landi Even before the COVID-19 pandemic, patients faced barriers getting connected with the right mental health care services. The current health crisis is exacerbating these challenges and adding new ones. Here's what Quartet Health and SilverCloud Health are working on together to try to open up access to mental health care. read more By Fraiser Kansteiner The glass used to make vials for vaccines and other medications is scarce, and with the looming need to store and distribute COVID-19 shots on a massive scale, Honeywell aims to step in with a new line of plastic alternatives dubbed Aclar Edge. read more By Ben Adams As the pandemic rages on and clinical trials are becoming increasingly siteless, eSource trial firm Clinical Ink has become an M&A target, being bought up this week by GI Partners. read more By Angus Liu Count Bayer as another company hurt by pandemic-related business slowdowns. During the second quarter, the company suffered from declines in its women’s health and ophthalmology departments, and the situation was only worsened by a newly implemented price cut in China. read more |
